Prostate Cancer - Results from #2200

From Screening to Mortality Reduction: An Overview of Empirical Data on the Patient Journey in European Randomized Study of Screening for Prostate Cancer Rotterdam After 21 Years of Follow-up and a Reflection on Quality of Life. September 12, 2023

Clinical Significance of Radical Prostatectomy in Clinical Lymph Node Metastasis in Prostate Cancer. September 11, 2023

Biochemical Recurrence and Risk of Mortality Following Radiotherapy or Radical Prostatectomy. September 11, 2023

Relative search popularity of five advanced prostate cancer medications using Google Trends. September 11, 2023

Prognostic Value of End-of-Treatment PSMA PET/CT in Patients Treated with 177Lu-PSMA Radioligand Therapy: A Retrospective, Single-Center Analysis. September 11, 2023

Biochemical recurrence in patients with prostate cancer after primary definitive therapy: treatment based on risk stratification. September 11, 2023

A systematic review evaluating the effectiveness of exercise training on physical condition in prostate cancer patients undergoing androgen deprivation therapy. September 11, 2023

Improved Quality of Life in Metastatic Castration-Resistant Prostate Cancer Patients Receiving Consecutive Cycles of 177Lu-PSMA I&T. September 11, 2023

Application of next-generation imaging in biochemically recurrent prostate cancer. September 11, 2023

Reirradiation salvage radiotherapy for recurrent prostate cancer after primary low-dose brachytherapy. September 8, 2023

IGF-1 axis changes with ADT and docetaxel in metastatic prostate cancer. September 8, 2023

The biology behind combining poly [ADP ribose] polymerase and androgen receptor inhibition for metastatic castration-resistant prostate cancer. September 8, 2023

Master transcription factor reprograming unleashes selective translation promoting castration resistance and immune evasion in lethal prostate cancer. September 8, 2023

Molecular features of prostate cancer post-neoadjuvant therapy in the Phase 3 CALGB 90203 trial. September 8, 2023

Quality rectal hydrogel placement allows for gel-enabled dose-escalated EBRT (GEDE-EBRT) without rectal interference in prostate cancer. September 7, 2023

State of the art and future challenges of urethra-sparing stereotactic body radiotherapy for prostate cancer: a systematic review of literature. September 7, 2023

Extraperitoneal robot-assisted radical prostatectomy with the Hugo™ RAS system: initial experience of a tertiary center with a high background in extraperitoneal laparoscopy surgery. September 7, 2023

Robot-assisted PSMA-radioguided surgery to assess surgical margins and nodal metastases in prostate cancer patients: report on three cases using an intraoperative PET-CT specimen imager. September 7, 2023

Focal therapy versus radical prostatectomy and external beam radiotherapy as primary treatment options for non-metastatic prostate cancer: results of a cost-effectiveness analysis. September 7, 2023

Image-guided radiation therapy produces lower acute and chronic gastrointestinal and genitourinary toxicity in prostate cancer patients. September 7, 2023

Page 111 of 1439